跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYOSUN SYRUP 5MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
HYOSUN SYRUP 5MG/5 ML
Approved
THERAPEUTIC
HYOSUN SYRUP 5MG/5 ML
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 20, 1993
Approval ID
fe88aaadb53e373e
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED - SINGAPORESUNWARD PHARMACEUTICAL SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
fe88aaadb53e373e
Drug Name
HYOSUN SYRUP 5MG/5 ML
Product Name
HYOSUN SYRUP 5MG/5 ML
Approval Number
SIN07433P
Approval Date
1993-05-20
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A03BB01
Atc Item Name
butylscopolamine
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
HYOSCINE N-BUTYLBROMIDE
5 mg/5 ml
HYOSCINE N-BUTYLBROMIDE
5 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 20, 1993
Approval ID
fe88aaadb53e373e
Type
Therapeutic
Back to HSA Approvals